Opinions
Bruce Campbell (2)
C21 Investments Inc.
CXXI-CN
TOP PICK
Jan 30, 2019
A cannabis player that just acquired one of the biggest dispensaries in Nevada. It trades at 1 times sales, whereas peers are 3-5 times -- lots of upside here. (Analysts price target not reported). Yield 0%.
$1.040
Stock price when the opinion was issued
0
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
He owns it and says it will become one of the most profitable companies in the US cannibas space once it closes it Nevada acquisition. The market has reflected the concern over the closing. It should be closed by early-January, he thinks. They have financing he believes with a banking interest. Management sees 2019 exit around $79 million revenues and 30% margins. With postivive cashflow next year, he thinks this leaves room for further acquisitions.
0
BUY
He has had it as a past pick. This morning they came out with data. They have had a fantastic run rate. There is a valuation discrepancy. They will acquisitive. They just opened up a dispensary and traffic numbers are higher than they expected. They will have more repeat customers and more loyalty than a Las Vegas store.
0
TOP PICK
PAST TOP PICK
(A Top Pick Aug 09/19, Up 10%) A cannabis company in Nevada. Like Indus, they cleaned up their situation and are turning around. They bought a large dispensary in Nevada near Reno. An overhang was owing the vendor a lot of money, but that vendor has become the new CEO has fixed that debt. CXXI is now cash-flow positive. Down the road, they will do more acquisitions.
0
Advertising